EU HTA Joint Clinical Assessment: are patients with rare disease going to lose out?

Ítems similars

• Leveraging EUnetHTA’s conceptual framework to compare HTA decision drivers in France, Italy, and Germany from a manufacturer’s point of view
  per: Giovanni Giuliani, et al.
  Publicat: (2018-09-01)
• The PICO Puzzle: Can Public Data Predict EU HTA Expectations for All EU Countries?
  per: Karolin Eberle, et al.
  Publicat: (2025-06-01)
• European Joint Clinical Assessment PICO Scoping Process: Analysis of Current Approaches and Recommendations
  per: Kalpana D’Oca, et al.
  Publicat: (2025-12-01)
• Preparing for the EU HTA Regulation: Insights from the Dutch Perspective
  per: Anne Willemsen, et al.
  Publicat: (2025-07-01)
• HTA CORE MODEL
  per: R. I. Yagudina, et al.
  Publicat: (2015-03-01)